NMPA Approval

Omalizumab for Injection

Approval Number

国药准字SJ20170042

Registration Date

January 27, 2022

Previous Approval Numbers

S20170042

Drug Information

Generic Name

注射用奥马珠单抗

Trade Name

茁乐

Dosage Form

注射剂

Strength

150mg/瓶

Drug Type

生物制品

Registration Date

January 27, 2022

Expiry Date

January 26, 2027

Company Address

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

Company Address

Schaffhauserstrasse, 4332 Stein, Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.